Optometry Times Newsletter

What we know about blue light science and research in 2020

It’s not about the intensity; it’s about the exposure. Length of time on the computer, dilation of the pupil during device use—these factors could make a difference over a lifetime of blue light exposure.

How to determine treatment for a patient with a Roth spot

Occasionally, the primary-care OD may encounter a Roth spot, or a white centered hemorrhage. Classically associated with bacterial endocarditis, leukemia and anemia, these lesions are actually linked to a myriad of systemic conditions, often leaving the provider wondering what tests should be ordered or what systemic work-up is needed.

Find out

Don’t shy away from steroid use for surgery patients

There are now more drugs to personalize the anti-inflammatory drop of choice. This is exemplified when looking at a procedure such as the Kamra Inlay (CorneaGen), which works best when the cornea is free of edema or inflammation.
However, it is known that subclinical and clinical inflammation follows patients in their daily activities, especially after surgery. ODs can now use effective penetrating steroids, less IOP spiking, and better dosing for these patients for a more prolonged taper.

Register Today For OIS@SECO

In two days OIS will be in Atlanta for the 2nd annual Ophthalmic Innovation Summit @SECO. Register today to be among the leading KOLs, start-up CEOs, Investors and Industry Executives! Learn more:

http://bit.ly/31vjwKd

New perspectives and technologies affect glaucoma treatment